Quarterly Earnings

The lender hits its highest rank on Fortune's Best Companies list, but does a celebrated internal culture translate to success in a challenging economy?

As Corebridge Financial prepares to report Q1 results on May 4, investors are watching to see if its 2025 momentum can weather new industry challenges.

Amidst major losses and a declining core business, China's Quhuo bets its future on a high-stakes pivot to housekeeping and vehicle exports, fueled by AI.

PNC declared a steady $1.70 dividend, underscoring its robust financial health and commitment to delivering consistent shareholder returns.

Cheer Holding enacts a 1-for-3 reverse stock split to avoid delisting. But with a history of similar moves, what does this mean for investors?

Following a strong earnings report, Rezolve AI's CEO Dan Wagner has acquired 9 million shares, signaling deep insider confidence in its vision.

IFF targets the booming pet wellness market with PureStrong™, a probiotic built from canine science. Is this the future of dog digestive health?

A Pennsylvania marketing firm and its clients land on prestigious growth lists, proving a specialized strategy in trade industries is a powerful formula.

With international sales now making up nearly 60% of its revenue, the heavy industry giant is diversifying into humanoid robots and emerging markets.

HubSpot adds MongoDB CFO Mike Berry to its board, a strategic move to bolster financial discipline and guide its ambitious AI-driven global expansion.

As TI preps its Q1 2026 earnings call, all eyes are on its performance as an indicator for the industrial, auto, and broader semiconductor sectors.

With a massive profit jump, Vancity doubles down on community investment and branch expansion, challenging the Canadian banking industry's current trends.

The investment firm reports a 213% revenue surge after a major acquisition, but a 'going concern' note raises questions about its financial footing.

With a unique drug that preserves muscle while shedding fat, a newly fortified biotech is set to challenge the titans of the weight-loss market.

As Stryker preps its Q1 2026 report, all eyes are on whether the MedTech giant can sustain its momentum amid new products and industry-wide pressures.

Nexera Technologies reports 23% revenue growth while executing a bold strategic shift from online retail to the high-stakes AI homeland security market.

With tax refunds up 10%, experts offer a roadmap to turn that cash into real wealth, from debt reduction to hedging with gold. Here's how.

XPeng reports an 80% monthly sales jump but a yearly decline, while launching a major strategic expansion into Mexico and Latin America.

The energy firm's new agreement with Bahiagás boosts sales by 25% and fuels record production, signaling a profitable future in Brazil's evolving market.

A one-time gain gave the micro-cap a profitable quarter, but rising costs and reliance on a single large asset raise questions about its long-term stability.